Moleculin Announces Proposed Underwritten Public Offering

Go back to Moleculin Announces Proposed Underwritten Public Offering
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.61 +0.04 (7.02%)
Previous Close $0.57    52 Week High $9.58 
Open $0.58    52 Week Low $2.34 
Day High $0.62    P/E N/A 
Day Low $0.55    EPS $-0.34 
Volume 365,222